Compare MO & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MO | ELV |
|---|---|---|
| Founded | 1822 | 1944 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.8B | 85.7B |
| IPO Year | 1994 | 2001 |
| Metric | MO | ELV |
|---|---|---|
| Price | $71.78 | $384.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 19 |
| Target Price | $65.00 | ★ $383.56 |
| AVG Volume (30 Days) | ★ 6.6M | 1.6M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 6.22% | 1.83% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.30 | ★ 8.00 |
| Revenue | $23,279,000,000.00 | ★ $199,125,000,000.00 |
| Revenue This Year | $3.49 | N/A |
| Revenue Next Year | $0.36 | $3.07 |
| P/E Ratio | $55.38 | ★ $47.96 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $54.70 | $273.71 |
| 52 Week High | $74.44 | $426.98 |
| Indicator | MO | ELV |
|---|---|---|
| Relative Strength Index (RSI) | 54.31 | 44.37 |
| Support Level | $68.13 | $307.76 |
| Resistance Level | $74.20 | $408.00 |
| Average True Range (ATR) | 1.45 | 11.00 |
| MACD | -0.07 | -3.91 |
| Stochastic Oscillator | 65.32 | 5.05 |
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 40% share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev, and a 41% stake in cannabis manufacturer Cronos. In reduced-risk products, it acquired vaping company Njoy Holdings in 2023, operates a joint venture with Japan Tobacco in the heated tobacco category for the US, and sells the On brand in nicotine pouches.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.